The Madison biotechnology industry has developed an impressive legacy of success. Over $3 billion of shareholder value has been created, highlighted by the major transactions below.
| Company | Liquidity Event | Valuation |
|---|
| Agracetus Plant Genetics Division | 1996 – Monsanto Acquisition | $150M |
| PanVera | 2000 – Aurora Acquisition | $85M |
| Lunar Corporation | 2000 – GE Healthcare Acquisition | $142M |
| PowderJect Vaccines (& parent) | 2003 – Chiron Acquisition | $878M |
| Tetrionics | 2004 - Sigma Aldrich Acquisition | $85M |
| Bone Care International | 2006 – Genzyme Acquisition | $600M |
| TomoTherapy | 2007 – IPO | >$800M |
| NimbleGen Systems | 2007 – Roche Acquisition | $273M |
| Third Wave Technologies | 2008 – Hologic Acquisition | $580M |
| Mirus Bio Corporation | 2008 – Roche Acquisition | $125M |